Q2 FY2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: Telix Pharmaceuticals(TLX) the Revenue is 239.37 M (--%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
0.24B--
0.24B--
+0.00B--%
EBIT
TBA--
0.01B--
----
EPS
TBA--
0--
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf